Epigenetic Modulation of Mood Disorders
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mood disorders are expressed in many heterogeneous forms, varying from anxiety to severe major clinical depression. The disorders are expressed in individual variety through manifestations governed by co-morbidities, symptom frequency, severity, and duration, and the effects of genes on phenotypes. The underlying etiologies of mood disorders consist of complex interactive operations of genetic and environmental factors. The notion of endophenotypes, which encompasses the markers of several underlying liabilities to the disorders, may facilitate efforts to detect and define, through staging, the genetic risks inherent to the extreme complexity of disease state. AIMS: This review evaluates the role of genetic biomarkers in assisting clinical diagnosis, identification of risk factors, and treatment of mood disorders. METHODS: Through a systematic assessment of studies investigating the epigenetic basis for mood disorders, the present review examines the interaction of genes and environment underlying the pathophysiology of these disorders. RESULTS: The majority of research findings suggest that the notion of endophenotypes, which encompasses the markers of several underlying liabilities to the disorders, may facilitate efforts to detect and define, through staging, the genetic risks inherent to the extreme complexity of the disease states. Several strategies under development and refinement show the propensity for derivation of essential elements in the etiopathogenesis of the disorders affecting drug-efficacy, drug metabolism, and drug adverse effects, e.g., with regard to selective serotonin reuptake inhibitors. These include: transporter gene expression and genes encoding receptor systems, hypothalamic-pituitary-adrenal axis factors, neurotrophic factors, and inflammatory factors affecting neuroimmune function. Nevertheless, procedural considerations of pharmacogenetics presume the parallel investment of policies and regulations to withstand eventual attempts at misuse, thereby ensuring patient integrity. CONCLUSIONS: Identification of genetic biomarkers facilitates choice of treatment, prediction of response, and prognosis of outcome over a wide spectrum of symptoms associated with affective states, thereby optimizing clinical practice procedures. Epigenetic regulation of primary brain signaling, e.g., serotonin and hypothalamic-pituitary-adrenal function, and factors governing their metabolism are necessary considerations. The participation of neurotrophic factors remains indispensable for neurogenesis, survival, and functional maintenance of brain systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708473 · Cited by 3,898 · cited 1×
“Quality-of-life and psychological health are increasingly found to be intimately related [11].”
BackgroundBeyond diathesis stress: differential susceptibility to environmental influences
Belsky, J., & Pluess, M. (2009) · Psychological Bulletin · doi:10.1037/a0017376 · Cited by 3,039 · cited 1×
“The notion of “differential-susceptibility” incorporates the specific genetic variants of individuals and the extent to which they are affected by environmental experiences [200-203].”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614 · cited 1×
“The former, high-affinity receptors, are implicated in the appraisal process and acute stress response onset, and the latter, low-affinity receptors, promote adaptation and recovery from stress [148].”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270 · cited 2×
“Both the release of CRH and arginine vasopressin in the parvocellular neurons of the paraventricular nuclei of the hypothalamus mediate parallel activation of the sympathetic nervous system and the HPA, in turn activating proopiomelanocortin synthesis, processed to adrenocorticotrophin hormone, which induces secretion…”
Kim-Cohen, J., Caspi, A., Moffitt, T. E., Harrington, H., Milne, B. J., & Poulton, R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.709 · Cited by 2,025
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Differential susceptibility to the environment: an evolutionary--neurodevelopmental theory
Ellis, B. J., Boyce, W. T., Belsky, J., Bakermans-Kranenburg, M. J., & van Ijzendoorn, M. H. (2011) · Development and Psychopathology · doi:10.1017/s0954579410000611 · Cited by 1,564 · cited 1×
“The notion of “differential-susceptibility” incorporates the specific genetic variants of individuals and the extent to which they are affected by environmental experiences [200-203].”
BackgroundNanni, V., Uher, R., & Danese, A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020335 · Cited by 1,480
Binder, E. B. (2008) · JAMA · doi:10.1001/jama.299.11.1291 · Cited by 1,362
Adolescent Onset of the Gender Difference in Lifetime Rates of Major Depression: A Theoretical Model
Cyranowski, J. M., Frank, E., Young, E., & Shear, M. K. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.21 · Cited by 1,276 · cited 1×
“Female sufferers from the disorder remain almost twice as many as male sufferers with the relative gender proportions evident already during adolescence [9].”
BackgroundFerrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., & Whiteford, H. A. (2013) · Psychological Medicine · doi:10.1017/s0033291712001511 · Cited by 1,230 · cited 1×
“Both unipolar depression and bipolar disorder present clinically severe conditions characterized by recurring episodes of depressive symptom categories, and in the latter periods of mania, with a life-long lasting prevalence [29-31].”
BackgroundDepression and cortisol responses to psychological stress: A meta-analysis
Burke, H. M., Davis, M. C., Otte, C., & Mohr, D. C. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.02.010 · Cited by 1,194 · cited 1×
“The deregulation and the irregularity of the HPA axis presents a major aspect of symptom and biomarker profiles in depressive disorders [137-139], focusing on the role of elevated cortisol [140] and the putative AD-induced normalization of HPA function [141].”
BackgroundIncreased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Mood disorders and allostatic load
McEwen, B. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00177-x · Cited by 1,135
Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., & Weinberger, D. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06690.2003 · Cited by 1,045 · cited 1×
“In the functional rs6265 (Val66Met) polymorphism, the Met allele is associated with decreased activity-dependent BDNF secretion [186], structural brain abnormalities in limbic regions [187], impaired hippocampal activity [188], impaired associative fear learning [189], defective BDNF secretion, and increased anxiety-r…”
BackgroundCortisol awakening response and psychosocial factors: a systematic review and meta-analysis
Chida, Y., & Steptoe, A. (2009) · Biological Psychology · doi:10.1016/j.biopsycho.2008.10.004 · Cited by 1,032 · cited 1×
“First, cortisol awakening rise, reflecting the natural response to waking-up, with 50-75% increases in cortisol within 30 min, is modulated by sleep patterns, seasonal variation, daily activities, health indicators, and stressors/trauma [112,113].”
BackgroundVulnerability genes or plasticity genes?
Belsky, J., Jonassaint, C., Pluess, M., Stanton, M., Brummett, B., & Williams, R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.44 · Cited by 1,017 · cited 1×
“The notion of “differential-susceptibility” incorporates the specific genetic variants of individuals and the extent to which they are affected by environmental experiences [200-203].”
BackgroundBinder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968 · cited 2×
“The FKBP5 and CRH-R1 polymorphisms are associated with glucocorticoid resistance and reduced negative feedback of the HPA axis [92].”
BackgroundCastrén, E., & Rantamäki, T. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20758 · Cited by 864
Anxiety Disorders During Childhood and Adolescence: Origins and Treatment
Rapee, R. M., Schniering, C. A., & Hudson, J. L. (2009) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.032408.153628 · Cited by 821 · cited 1×
“High rates remission and treatment response are predicted by symptom severity [178], parental psychopathology [179], and co-morbid mood disorder [180].”
BackgroundInteraction between BDNF and Serotonin: Role in Mood Disorders
Martinowich, K., & Lu, B. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301571 · Cited by 793 · cited 1×
“The secretion of BDNF is activity-dependent with reduced secretion linked to the effects of stress and mood disorders [182,183]; AD treatments generally elevate BDNF secretion [184,185].”
BackgroundMajor depressive disorder and hypothalamic-pituitary-adrenal axis activity
Vreeburg, S. A., Hoogendijk, W. J. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.50 · Cited by 792
Research Review: The neurobiology and genetics of maltreatment and adversity
McCrory, E., De Brito, S. A., & Viding, E. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02271.x · Cited by 598
Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis
Serretti, A., & Chiesa, A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a5233f · Cited by 583 · cited 1×
“Consequently, description and prediction of the extent to which the gene profiles of individuals affect their responses to pharmacogenetic therapeutic interventions may be achieved [193,194] through applied notions of genes, proteins, and SNPs [195].”
BackgroundAlterations in 5-HT 1B Receptor Function by p11 in Depression-Like States
Svenningsson, P., Chergui, K., Rachleff, I., Flajolet, M., Zhang, X., Yacoubi, M. E., Vaugeois, J.-M., Nomikos, G. G., & Greengard, P. (2006) · Science · doi:10.1126/science.1117571 · Cited by 572 · cited 1×
“ADs elevate p11 levels in brain regions and P11 gene therapy was antidepressive: p11 concentrations were reduced in post-mortem brain tissues of patients presenting depressive disorder and by the expressions of depression-like behavioral phenotypes [212,213].”
BackgroundGatt, J. M., Nemeroff, C. B., Dobson-Stone, C., Paul, R. H., Bryant, R. A., Schofield, P. R., Gordon, E., Kemp, A. H., & Williams, L. M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.143 · Cited by 525 · cited 1×
“Nevertheless, significant associations have been reported between Met allele carriers and increased introversion [163], increased harm avoidance [164], and significant gene-gene and gene-environment interactions pertaining to anxiety- and depression-linked endophenotypes [165-167].”
BackgroundMaternal methyl supplements increase offspring DNA methylation at Axin fused
Waterland, R. A., Dolinoy, D. C., Lin, J., Smith, C. A., Shi, X., & Tahiliani, K. G. (2006) · genesis · doi:10.1002/dvg.20230 · Cited by 480
Bandelow, B., Sher, L., Bunevicius, R., Hollander, E., Kasper, S., Zohar, J., Möller, H.-J., WFSBP Task Force on Mental Disorders in Primary Care, & WFSBP Task Force on Anxiety Disorders, O. A. P. (2012) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2012.667114 · Cited by 428
Uher, R., & McGuffin, P. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.123 · Cited by 424
Epigenetic programming of the stress response in male and female rats by prenatal restraint stress
Darnaudéry, M., & Maccari, S. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.11.004 · Cited by 412 · cited 1×
“ISSN:2157-7412 JGSGT, an open access journal traumatic stress [130,135,136], and frequently are accompanied by relative elevations of glucocorticoid stress hormones.”
BackgroundBoyle, M. P., Brewer, J. A., Funatsu, M., Wozniak, D. F., Tsien, J. Z., Izumi, Y., & Muglia, L. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406458102 · Cited by 378 · cited 1×
“The deregulation and the irregularity of the HPA axis presents a major aspect of symptom and biomarker profiles in depressive disorders [137-139], focusing on the role of elevated cortisol [140] and the putative AD-induced normalization of HPA function [141].”
BackgroundEpigenetic regulation of gene expression in physiological and pathological brain processes
Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354 · cited 1×
“Second, HPA axis challenge using the dexamethasone suppression test indicates non-suppression effects in mood disorder patients [117-119].”
MethodIsing, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341 · cited 1×
“Second, HPA axis challenge using the dexamethasone suppression test indicates non-suppression effects in mood disorder patients [117-119].”
Methodvan Rossum, E. F. C., Koper, J. W., Huizenga, N. A. T. M., Uitterlinden, A. G., Janssen, J. A. M. J. L., Brinkmann, A. O., Grobbee, D. E., de Jong, F. H., van Duyn, C. M., Pols, H. A. P., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3128 · Cited by 329
Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence
Adam, E. K., Doane, L. D., Zinbarg, R. E., Mineka, S., Craske, M. G., & Griffith, J. W. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.12.007 · Cited by 315 · cited 1×
“Patients presenting mood disorders show higher basal cortisol awakening rise levels [114-116].”
BackgroundHormones and the Stressed Brain
DE KLOET, E. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.001 · Cited by 314
Polanczyk, G., Caspi, A., Williams, B., Price, T. S., Danese, A., Sugden, K., Uher, R., Poulton, R., & Moffitt, T. E. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.114 · Cited by 285 · cited 1×
“Epigenetic changes wrought by adverse environments showed lasting changes to HPA functioning [130,131] as well as mood disorders [132,133].”
BackgroundGene–environment interactions: early life stress and risk for depressive and anxiety disorders
Nugent, N. R., Tyrka, A. R., Carpenter, L. L., & Price, L. H. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2151-x · Cited by 269 · cited 1×
“ISSN:2157-7412 JGSGT, an open access journal traumatic stress [130,135,136], and frequently are accompanied by relative elevations of glucocorticoid stress hormones.”
BackgroundTyrka, A. R., Price, L. H., Gelernter, J., Schepker, C., Anderson, G. M., & Carpenter, L. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.012 · Cited by 264 · cited 1×
“[93] addressed the potential role of polymorphisms in genes regulating the HPA axis, thereby affecting putatively AD drug efficacy.”
BackgroundGlucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain
Patel, P. D., Lopez, J. F., Lyons, D. M., Burke, S., Wallace, M., & Schatzberg, A. F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00035-2 · Cited by 252 · cited 1×
“Cortisol effects are exerted through glucocorticoid and mineralocorticoid receptors, with extremely high densities of glucocorticoid receptors in the hippocampus, dentate gyrus, prefrontal cortex, paraventricular nucleus of the hypothalamus, and amygdala, and mineralocorticoid mainly in the hippocampus, prefrontal cor…”
BackgroundClinical Features Associated with Glucocorticoid Receptor Polymorphisms: An Overview
Manenschijn, L., van den Akker, E. L. T., Lamberts, S. W. J., & van Rossum, E. F. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05013.x · Cited by 249
The evolutionary origins of mood and its disorders
Nettle, D., & Bateson, M. (2012) · Current Biology · doi:10.1016/j.cub.2012.06.020 · Cited by 230 · cited 1×
“Mood disorders are an associated group of diagnoses in the Diagnostic and Statistical Manual of Mental Disorders (DSM IV TR) classification system, wherein a disturbance in the person’s mood, or emotional or affective status, is considered to present the main underlying feature [28].”
BackgroundMehta, D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.50 · Cited by 200 · cited 1×
“FKBP5 (FK506 binding protein 5), a protein encoded by the FKPB5 gene and involved in immunoregulation, is implicated in posttraumatic stress disorder, depression, and anxiety [88,89].”
BackgroundVreeburg, S. A., Kruijtzer, B. P., van Pelt, J., van Dyck, R., DeRijk, R. H., Hoogendijk, W. J. G., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.024 · Cited by 193 · cited 1×
“First, cortisol awakening rise, reflecting the natural response to waking-up, with 50-75% increases in cortisol within 30 min, is modulated by sleep patterns, seasonal variation, daily activities, health indicators, and stressors/trauma [112,113].”
BackgroundAlt, S. R., Turner, J. D., Klok, M. D., Meijer, O. C., Lakke, E. A. J. F., DeRijk, R. H., & Muller, C. P. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.09.001 · Cited by 184
Epigenetic mechanisms mediating vulnerability and resilience to psychiatric disorders
Dudley, K. J., Li, X., Kobor, M. S., Kippin, T. E., & Bredy, T. W. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.12.016 · Cited by 180 · cited 1×
“Epigenetic mechanisms altering the activities of genes mediated through early life experiences leave indelible chemical marks within brain tissue thereby influencing both physical and neuropsychiatric health [43].”
BackgroundNeuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167
Melas, P. A., Rogdaki, M., Lennartsson, A., Björk, K., Qi, H., Witasp, A., Werme, M., Wegener, G., Mathé, A. A., Svenningsson, P., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000940 · Cited by 157
Epigenetic regulation of serotonin transporter expression and behavior in infant rhesus macaques
Kinnally, E. L., Capitanio, J. P., Leibel, R., Deng, L., LeDuc, C., Haghighi, F., & Mann, J. J. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00588.x · Cited by 155
Appelhof, B. C., Huyser, J., Verweij, M., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Tijssen, J. G. P., Wiersinga, W. M., & Schene, A. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.008 · Cited by 154 · cited 1×
“Second, HPA axis challenge using the dexamethasone suppression test indicates non-suppression effects in mood disorder patients [117-119].”
MethodLopez, M. F., Doremus-Fitzwater, T. L., & Becker, H. C. (2011) · Alcohol · doi:10.1016/j.alcohol.2010.08.017 · Cited by 146 · cited 1×
“Early life stress exerts long-lasting, even permanent, effects upon hippocampus associated cognitive functioning [102]; this regime disrupts development of neural systems mediating rewardrelated behaviors [103].”
BackgroundNatsuaki, M. N., Klimes-Dougan, B., Ge, X., Shirtcliff, E. A., Hastings, P. D., & Zahn-Waxler, C. (2009) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374410902976320 · Cited by 145
Reversal of Depressed Behaviors in Mice by p11 Gene Therapy in the Nucleus Accumbens
Alexander, B., Warner-Schmidt, J., Eriksson, T. M., Tamminga, C., Arango-Lievano, M., Ghose, S., Vernov, M., Stavarache, M., Musatov, S., Flajolet, M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001079 · Cited by 140 · cited 1×
“p11 was knocked down in the nucleus accumbens or in the anterior cingulate, and viral vectors were used to insert p11 into the nucleus accumbens of mice with knocked-out p11 [210].”
Bet, P. M., Penninx, B. W. J. H., Bochdanovits, Z., Uitterlinden, A. G., Beekman, A. T. F., van Schoor, N. M., Deeg, D. J. H., & Hoogendijk, W. J. G. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30886 · Cited by 138
Nilsen, T. S., Eisemann, M., & Kvernmo, S. (2013) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0316-3 · Cited by 134 · cited 1×
“[65] performed a systematic review of 32 anxiety studies and 13 depression studies that met predefined methodological criteria comprising client demographic characteristics (age, gender, ethnicity, IQ) and clinical factors (duration, type of diagnosis, pre-treatment severity, co-morbidity).”
BackgroundDeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117
Stein, A. D., Pierik, F. H., Verrips, G. H. W., Susser, E. S., & Lumey, L. H. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181b5f227 · Cited by 103 · cited 1×
“Epigenetic changes wrought by adverse environments showed lasting changes to HPA functioning [130,131] as well as mood disorders [132,133].”
BackgroundAssociation between pubertal development and depressive symptoms in girls from a UK cohort
Joinson, C., Heron, J., Araya, R., Paus, T., Croudace, T., Rubin, C., Marcus, M., & Lewis, G. (2012) · Psychological Medicine · doi:10.1017/s003329171200061x · Cited by 99 · cited 1×
“[64] found that depressive symptoms among girls during mid-adolescence were more strongly influenced by breast stage than timing of menarche.”
BackgroundNeurogenic Effects of Fluoxetine Are Attenuated in p11 (S100A10) Knockout Mice
Egeland, M., Warner-Schmidt, J., Greengard, P., & Svenningsson, P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.024 · Cited by 94
Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response
Keers, R., & Uher, R. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-011-0251-x · Cited by 94
Zou, Y.-F., Wang, F., Feng, X.-L., Li, W.-F., Tao, J.-H., Pan, F.-M., Huang, F., & Su, H. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.019 · Cited by 61 · cited 1×
“FKBP5 (FK506 binding protein 5), a protein encoded by the FKPB5 gene and involved in immunoregulation, is implicated in posttraumatic stress disorder, depression, and anxiety [88,89].”
Background
Cited by
Singh, M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00925 · Cited by 337
Garcia, D., Al Nima, A., & Kjell, O. N. E. (2014) · PeerJ · doi:10.7717/peerj.259 · Cited by 130
“These researchers concluded that positive affect might serve as an anti-depressive factor as well as a facilitative factor for happiness and life satisfaction (see also Archer & Kostrzewa, 2013 ; Archer et al., 2013 ; Lindahl & Archer, 2013 ).”
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery
Blum, K., Thompson, B., Demotrovics, Z., Femino, J., Giordano, J., Oscar-Berman, M., Teitelbaum, S., Smith, D. E., Roy, A. K., Agan, G., et al. (2015) · Journal of Reward Deficiency Syndrome · doi:10.17756/jrds.2015-008 · Cited by 73
Ignácio, Z. M., Réus, G. Z., Abelaira, H. M., & Quevedo, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.036 · Cited by 65
Early life trauma, depression and the glucocorticoid receptor gene—An epigenetic perspective
Smart, C., Strathdee, G., Watson, S., Murgatroyd, C., & McAllister-Williams, R. H. (2015) · Psychological Medicine · doi:10.1017/s0033291715001555 · Cited by 61
Metadata
- Authors
- T, A.
- Venue
- Journal of Genetic Syndromes & Gene Therapy
- Publisher
- OMICS Publishing Group
- Published
- 2013
- Volume
- 04
- Issue
- 01
- ISSN
- 2157-7412 (ISSN-L)
- OpenAlex
- W2008072894
- Cited by
- 51
- References
- 64
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.